Structure

Physi-Chem Properties

Molecular Weight:  942.32
Volume:  870.917
LogP:  1.415
LogD:  0.572
LogS:  -3.703
# Rotatable Bonds:  16
TPSA:  305.35
# H-Bond Aceptor:  21
# H-Bond Donor:  8
# Rings:  14
# Heavy Atoms:  21

MedChem Properties

QED Drug-Likeness Score:  0.097
Synthetic Accessibility Score:  7.987
Fsp3:  0.674
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.795
MDCK Permeability:  7.100372749846429e-05
Pgp-inhibitor:  0.059
Pgp-substrate:  1.0
Human Intestinal Absorption (HIA):  0.903
20% Bioavailability (F20%):  0.812
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.134
Plasma Protein Binding (PPB):  45.20929718017578%
Volume Distribution (VD):  0.395
Pgp-substrate:  12.490682601928711%

ADMET: Metabolism

CYP1A2-inhibitor:  0.002
CYP1A2-substrate:  0.998
CYP2C19-inhibitor:  0.012
CYP2C19-substrate:  0.182
CYP2C9-inhibitor:  0.004
CYP2C9-substrate:  0.001
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.028
CYP3A4-inhibitor:  0.503
CYP3A4-substrate:  0.146

ADMET: Excretion

Clearance (CL):  1.241
Half-life (T1/2):  0.72

ADMET: Toxicity

hERG Blockers:  0.15
Human Hepatotoxicity (H-HT):  0.1
Drug-inuced Liver Injury (DILI):  0.883
AMES Toxicity:  0.972
Rat Oral Acute Toxicity:  0.305
Maximum Recommended Daily Dose:  0.034
Skin Sensitization:  0.87
Carcinogencity:  0.917
Eye Corrosion:  0.003
Eye Irritation:  0.014
Respiratory Toxicity:  0.939

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC469421

Natural Product ID:  NPC469421
Common Name*:   Paeonidanin E
IUPAC Name:   n.a.
Synonyms:   Paeonidanin E
Standard InCHIKey:  FPEQOYMLKLIEMS-IYNAHQBOSA-N
Standard InCHI:  InChI=1S/C46H54O21/c1-40-14-24(48)23-13-45(40,63-36-32(53)30(51)28(49)25(16-47)61-36)42(23,19-59-34(55)21-9-5-3-6-10-21)38(65-40)58-17-26-29(50)31(52)33(54)37(62-26)64-46-15-27-43(46,20-60-35(56)22-11-7-4-8-12-22)39-66-41(46,2)18-44(27,57)67-39/h3-12,23,25-33,36-39,47,49-54,57H,13-20H2,1-2H3/t23-,25-,26-,27+,28-,29-,30+,31+,32-,33-,36+,37+,38+,39-,40+,41+,42+,43+,44-,45-,46-/m1/s1
SMILES:  CC12CC(=O)C3CC1(C3(C(O2)OCC4C(C(C(C(O4)OC56CC7C5(C8OC6(CC7(O8)O)C)COC(=O)C9=CC=CC=C9)O)O)O)COC(=O)C1=CC=CC=C1)OC1C(C(C(C(O1)CO)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1078416
PubChem CID:   46883515
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30226 Paeonia albiflora Species Paeoniaceae Eukaryota roots n.a. n.a. PMID[19691309]
NPO30226 Paeonia albiflora Species Paeoniaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO30226 Paeonia albiflora Species Paeoniaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT848 Cell Line N9 Homo sapiens Inhibition = 101.9 % PMID[522330]
NPT848 Cell Line N9 Homo sapiens Inhibition = 101.8 % PMID[522330]
NPT848 Cell Line N9 Homo sapiens Inhibition = 88.8 % PMID[522330]
NPT848 Cell Line N9 Homo sapiens Inhibition = 69.2 % PMID[522330]
NPT848 Cell Line N9 Homo sapiens IC50 = 64700.0 nM PMID[522330]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC469421 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9748 High Similarity NPC469420
0.9245 High Similarity NPC469399
0.9187 High Similarity NPC477623
0.9182 High Similarity NPC469417
0.9057 High Similarity NPC34066
0.9057 High Similarity NPC469422
0.8994 High Similarity NPC133430
0.8994 High Similarity NPC469477
0.8976 High Similarity NPC477469
0.8976 High Similarity NPC477471
0.8976 High Similarity NPC477473
0.8976 High Similarity NPC477466
0.8938 High Similarity NPC5115
0.8938 High Similarity NPC469398
0.8931 High Similarity NPC477905
0.8916 High Similarity NPC102465
0.8902 High Similarity NPC150893
0.8902 High Similarity NPC295408
0.8902 High Similarity NPC329960
0.8876 High Similarity NPC477617
0.8868 High Similarity NPC469415
0.8812 High Similarity NPC472548
0.8805 High Similarity NPC469448
0.8805 High Similarity NPC222102
0.8805 High Similarity NPC303429
0.8795 High Similarity NPC477491
0.8765 High Similarity NPC106895
0.875 High Similarity NPC477488
0.8712 High Similarity NPC477735
0.8704 High Similarity NPC472549
0.8704 High Similarity NPC228204
0.8704 High Similarity NPC282239
0.8704 High Similarity NPC26033
0.8675 High Similarity NPC66193
0.8659 High Similarity NPC477736
0.8659 High Similarity NPC471102
0.8642 High Similarity NPC472005
0.8642 High Similarity NPC304876
0.8642 High Similarity NPC472022
0.8642 High Similarity NPC472030
0.8642 High Similarity NPC473414
0.8642 High Similarity NPC257213
0.8642 High Similarity NPC242262
0.8642 High Similarity NPC158333
0.8642 High Similarity NPC249471
0.8642 High Similarity NPC265395
0.8642 High Similarity NPC237549
0.8642 High Similarity NPC1173
0.8642 High Similarity NPC256142
0.8639 High Similarity NPC469396
0.8639 High Similarity NPC149002
0.8639 High Similarity NPC469459
0.8639 High Similarity NPC469458
0.8639 High Similarity NPC88176
0.8639 High Similarity NPC469419
0.8623 High Similarity NPC471134
0.8623 High Similarity NPC471493
0.8616 High Similarity NPC469513
0.8598 High Similarity NPC472393
0.8589 High Similarity NPC112523
0.8589 High Similarity NPC114410
0.8571 High Similarity NPC61891
0.8571 High Similarity NPC475567
0.8571 High Similarity NPC473468
0.8571 High Similarity NPC473557
0.8571 High Similarity NPC7095
0.8553 High Similarity NPC472572
0.8553 High Similarity NPC200471
0.8553 High Similarity NPC476973
0.8553 High Similarity NPC184817
0.8553 High Similarity NPC174982
0.8553 High Similarity NPC158663
0.8553 High Similarity NPC177940
0.8553 High Similarity NPC29704
0.8553 High Similarity NPC171525
0.8553 High Similarity NPC470159
0.8553 High Similarity NPC473088
0.8553 High Similarity NPC471104
0.8553 High Similarity NPC469349
0.8553 High Similarity NPC472571
0.8553 High Similarity NPC472575
0.8553 High Similarity NPC472568
0.8553 High Similarity NPC470157
0.8553 High Similarity NPC70403
0.8553 High Similarity NPC96903
0.8537 High Similarity NPC217091
0.8528 High Similarity NPC77719
0.8521 High Similarity NPC475175
0.8521 High Similarity NPC475531
0.8521 High Similarity NPC475198
0.8519 High Similarity NPC471103
0.8519 High Similarity NPC470153
0.8519 High Similarity NPC51602
0.8509 High Similarity NPC92293
0.8509 High Similarity NPC301556
0.8509 High Similarity NPC250046
0.8509 High Similarity NPC266265
0.8509 High Similarity NPC60509
0.8509 High Similarity NPC81698
0.8509 High Similarity NPC270590
0.8509 High Similarity NPC471101
0.8491 Intermediate Similarity NPC475122
0.8491 Intermediate Similarity NPC11685
0.8491 Intermediate Similarity NPC163719
0.8491 Intermediate Similarity NPC472569
0.8491 Intermediate Similarity NPC70716
0.8491 Intermediate Similarity NPC475759
0.8491 Intermediate Similarity NPC470152
0.8491 Intermediate Similarity NPC25768
0.8491 Intermediate Similarity NPC95265
0.8491 Intermediate Similarity NPC241951
0.8491 Intermediate Similarity NPC472570
0.8491 Intermediate Similarity NPC188865
0.8491 Intermediate Similarity NPC476974
0.8491 Intermediate Similarity NPC95810
0.8491 Intermediate Similarity NPC57628
0.8491 Intermediate Similarity NPC125106
0.8491 Intermediate Similarity NPC472573
0.8485 Intermediate Similarity NPC469771
0.8471 Intermediate Similarity NPC40138
0.8457 Intermediate Similarity NPC112216
0.8457 Intermediate Similarity NPC198455
0.8457 Intermediate Similarity NPC473214
0.8457 Intermediate Similarity NPC161239
0.8457 Intermediate Similarity NPC254558
0.8457 Intermediate Similarity NPC470245
0.8457 Intermediate Similarity NPC165260
0.8452 Intermediate Similarity NPC478073
0.8447 Intermediate Similarity NPC281717
0.8439 Intermediate Similarity NPC148185
0.8434 Intermediate Similarity NPC477467
0.8434 Intermediate Similarity NPC476784
0.8428 Intermediate Similarity NPC163087
0.8415 Intermediate Similarity NPC472658
0.8415 Intermediate Similarity NPC69425
0.8415 Intermediate Similarity NPC472657
0.8409 Intermediate Similarity NPC195114
0.8402 Intermediate Similarity NPC117943
0.8402 Intermediate Similarity NPC293568
0.8402 Intermediate Similarity NPC477627
0.8395 Intermediate Similarity NPC476975
0.8395 Intermediate Similarity NPC473215
0.8393 Intermediate Similarity NPC275477
0.8393 Intermediate Similarity NPC43304
0.8393 Intermediate Similarity NPC477188
0.8393 Intermediate Similarity NPC477190
0.8373 Intermediate Similarity NPC477474
0.8373 Intermediate Similarity NPC477472
0.8373 Intermediate Similarity NPC477470
0.8364 Intermediate Similarity NPC21410
0.8364 Intermediate Similarity NPC469456
0.8364 Intermediate Similarity NPC473670
0.8352 Intermediate Similarity NPC469418
0.8352 Intermediate Similarity NPC260300
0.8352 Intermediate Similarity NPC80360
0.8344 Intermediate Similarity NPC91730
0.8333 Intermediate Similarity NPC476077
0.8323 Intermediate Similarity NPC472556
0.8323 Intermediate Similarity NPC127857
0.8304 Intermediate Similarity NPC120012
0.8302 Intermediate Similarity NPC77493
0.8302 Intermediate Similarity NPC118080
0.8302 Intermediate Similarity NPC27377
0.8302 Intermediate Similarity NPC97947
0.8302 Intermediate Similarity NPC291599
0.8302 Intermediate Similarity NPC87448
0.8302 Intermediate Similarity NPC41481
0.8302 Intermediate Similarity NPC16912
0.8302 Intermediate Similarity NPC472576
0.8293 Intermediate Similarity NPC197037
0.8293 Intermediate Similarity NPC329657
0.8272 Intermediate Similarity NPC474935
0.8272 Intermediate Similarity NPC477737
0.8263 Intermediate Similarity NPC318447
0.8263 Intermediate Similarity NPC322048
0.8258 Intermediate Similarity NPC188217
0.8256 Intermediate Similarity NPC265600
0.8253 Intermediate Similarity NPC132599
0.8253 Intermediate Similarity NPC469730
0.8253 Intermediate Similarity NPC473632
0.8253 Intermediate Similarity NPC473611
0.8239 Intermediate Similarity NPC476094
0.8239 Intermediate Similarity NPC4341
0.8239 Intermediate Similarity NPC275592
0.8239 Intermediate Similarity NPC473112
0.8239 Intermediate Similarity NPC200592
0.8239 Intermediate Similarity NPC147880
0.8239 Intermediate Similarity NPC90614
0.8239 Intermediate Similarity NPC97667
0.8239 Intermediate Similarity NPC473613
0.8239 Intermediate Similarity NPC473109
0.8239 Intermediate Similarity NPC473085
0.8239 Intermediate Similarity NPC43241
0.8239 Intermediate Similarity NPC473758
0.8239 Intermediate Similarity NPC473081
0.8239 Intermediate Similarity NPC171207
0.8239 Intermediate Similarity NPC211137
0.8239 Intermediate Similarity NPC100913
0.8239 Intermediate Similarity NPC184747
0.8239 Intermediate Similarity NPC473060

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469421 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8057 Intermediate Similarity NPD7799 Discontinued
0.7944 Intermediate Similarity NPD8407 Phase 2
0.7877 Intermediate Similarity NPD8368 Discontinued
0.7709 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7676 Intermediate Similarity NPD8361 Approved
0.7676 Intermediate Similarity NPD8435 Approved
0.7676 Intermediate Similarity NPD8360 Approved
0.7663 Intermediate Similarity NPD8434 Phase 2
0.7596 Intermediate Similarity NPD8312 Approved
0.7596 Intermediate Similarity NPD8313 Approved
0.7592 Intermediate Similarity NPD8486 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7435 Intermediate Similarity NPD8485 Approved
0.7396 Intermediate Similarity NPD7700 Phase 2
0.7396 Intermediate Similarity NPD7699 Phase 2
0.738 Intermediate Similarity NPD8424 Clinical (unspecified phase)
0.7363 Intermediate Similarity NPD7228 Approved
0.7353 Intermediate Similarity NPD7236 Approved
0.7347 Intermediate Similarity NPD8319 Approved
0.7347 Intermediate Similarity NPD8320 Phase 1
0.7317 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD7240 Approved
0.7287 Intermediate Similarity NPD8150 Discontinued
0.7241 Intermediate Similarity NPD7239 Suspended
0.724 Intermediate Similarity NPD6535 Approved
0.724 Intermediate Similarity NPD6534 Approved
0.7239 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD7435 Discontinued
0.7135 Intermediate Similarity NPD8455 Phase 2
0.7135 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7121 Intermediate Similarity NPD7696 Phase 3
0.7121 Intermediate Similarity NPD7697 Approved
0.7121 Intermediate Similarity NPD7698 Approved
0.712 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD8151 Discontinued
0.7102 Intermediate Similarity NPD7458 Discontinued
0.7097 Intermediate Similarity NPD7074 Phase 3
0.7097 Intermediate Similarity NPD7472 Approved
0.7079 Intermediate Similarity NPD7874 Approved
0.7079 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7074 Intermediate Similarity NPD7808 Phase 3
0.7065 Intermediate Similarity NPD7701 Phase 2
0.7056 Intermediate Similarity NPD6778 Approved
0.7056 Intermediate Similarity NPD4965 Approved
0.7056 Intermediate Similarity NPD6779 Approved
0.7056 Intermediate Similarity NPD6781 Approved
0.7056 Intermediate Similarity NPD6780 Approved
0.7056 Intermediate Similarity NPD6782 Approved
0.7056 Intermediate Similarity NPD4967 Phase 2
0.7056 Intermediate Similarity NPD4966 Approved
0.7056 Intermediate Similarity NPD6776 Approved
0.7056 Intermediate Similarity NPD6777 Approved
0.7043 Intermediate Similarity NPD7054 Approved
0.7021 Intermediate Similarity NPD7685 Pre-registration
0.7021 Intermediate Similarity NPD7251 Discontinued
0.7017 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.701 Intermediate Similarity NPD8462 Phase 1
0.7 Intermediate Similarity NPD7871 Phase 2
0.7 Intermediate Similarity NPD7870 Phase 2
0.6989 Remote Similarity NPD3818 Discontinued
0.6978 Remote Similarity NPD6234 Discontinued
0.6971 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6968 Remote Similarity NPD6797 Phase 2
0.6961 Remote Similarity NPD7801 Approved
0.6931 Remote Similarity NPD6559 Discontinued
0.6923 Remote Similarity NPD6213 Phase 3
0.6923 Remote Similarity NPD6212 Phase 3
0.6923 Remote Similarity NPD6214 Clinical (unspecified phase)
0.69 Remote Similarity NPD6823 Phase 2
0.6895 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6889 Remote Similarity NPD37 Approved
0.6878 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6875 Remote Similarity NPD8404 Phase 2
0.6868 Remote Similarity NPD7057 Phase 3
0.6868 Remote Similarity NPD7058 Phase 2
0.6866 Remote Similarity NPD7680 Approved
0.6865 Remote Similarity NPD3787 Discontinued
0.6851 Remote Similarity NPD7819 Suspended
0.6848 Remote Similarity NPD5494 Approved
0.6809 Remote Similarity NPD3751 Discontinued
0.6796 Remote Similarity NPD7783 Phase 2
0.6796 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6778 Remote Similarity NPD4380 Phase 2
0.6772 Remote Similarity NPD5844 Phase 1
0.6763 Remote Similarity NPD7266 Discontinued
0.6758 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6755 Remote Similarity NPD7473 Discontinued
0.6745 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6743 Remote Similarity NPD4628 Phase 3
0.6743 Remote Similarity NPD8166 Discontinued
0.6739 Remote Similarity NPD7075 Discontinued
0.6728 Remote Similarity NPD5126 Approved
0.6728 Remote Similarity NPD5125 Phase 3
0.672 Remote Similarity NPD8127 Discontinued
0.672 Remote Similarity NPD7199 Phase 2
0.6716 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6705 Remote Similarity NPD6190 Approved
0.6704 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6702 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6702 Remote Similarity NPD6166 Phase 2
0.6702 Remote Similarity NPD6168 Clinical (unspecified phase)
0.67 Remote Similarity NPD7497 Discontinued
0.6687 Remote Similarity NPD8328 Phase 3
0.6685 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5761 Phase 2
0.6667 Remote Similarity NPD5760 Phase 2
0.6647 Remote Similarity NPD7961 Discontinued
0.6631 Remote Similarity NPD6959 Discontinued
0.663 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6629 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6627 Remote Similarity NPD7008 Discontinued
0.6614 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6596 Remote Similarity NPD6232 Discontinued
0.6593 Remote Similarity NPD6599 Discontinued
0.6587 Remote Similarity NPD7319 Approved
0.6564 Remote Similarity NPD8513 Phase 3
0.6564 Remote Similarity NPD8517 Approved
0.6564 Remote Similarity NPD8515 Approved
0.6564 Remote Similarity NPD8516 Approved
0.6561 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6557 Remote Similarity NPD7411 Suspended
0.6556 Remote Similarity NPD6273 Approved
0.6548 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6541 Remote Similarity NPD5402 Approved
0.6538 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6524 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6522 Remote Similarity NPD6801 Discontinued
0.6514 Remote Similarity NPD8059 Phase 3
0.6514 Remote Similarity NPD8058 Clinical (unspecified phase)
0.65 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6491 Remote Similarity NPD3764 Approved
0.6486 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6477 Remote Similarity NPD7702 Clinical (unspecified phase)
0.6473 Remote Similarity NPD7999 Approved
0.6471 Remote Similarity NPD3749 Approved
0.6462 Remote Similarity NPD7930 Approved
0.6452 Remote Similarity NPD3817 Phase 2
0.6448 Remote Similarity NPD3226 Approved
0.6432 Remote Similarity NPD1934 Approved
0.6417 Remote Similarity NPD7768 Phase 2
0.641 Remote Similarity NPD6765 Approved
0.641 Remote Similarity NPD6764 Approved
0.6409 Remote Similarity NPD2532 Approved
0.6409 Remote Similarity NPD2534 Approved
0.6409 Remote Similarity NPD2533 Approved
0.6407 Remote Similarity NPD7507 Approved
0.6402 Remote Similarity NPD7741 Discontinued
0.64 Remote Similarity NPD7097 Phase 1
0.6384 Remote Similarity NPD2346 Discontinued
0.6376 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6369 Remote Similarity NPD7003 Approved
0.6358 Remote Similarity NPD2629 Approved
0.6354 Remote Similarity NPD6799 Approved
0.6339 Remote Similarity NPD5403 Approved
0.6331 Remote Similarity NPD7736 Approved
0.633 Remote Similarity NPD3882 Suspended
0.6325 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6324 Remote Similarity NPD7028 Phase 2
0.6319 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6319 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6319 Remote Similarity NPD4198 Discontinued
0.6319 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6319 Remote Similarity NPD5401 Approved
0.6313 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6312 Remote Similarity NPD2181 Clinical (unspecified phase)
0.631 Remote Similarity NPD1465 Phase 2
0.631 Remote Similarity NPD2801 Approved
0.6287 Remote Similarity NPD7457 Clinical (unspecified phase)
0.6281 Remote Similarity NPD6784 Approved
0.6281 Remote Similarity NPD6785 Approved
0.627 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6265 Remote Similarity NPD8296 Approved
0.6265 Remote Similarity NPD8033 Approved
0.6265 Remote Similarity NPD8380 Approved
0.6265 Remote Similarity NPD8335 Approved
0.6265 Remote Similarity NPD8379 Approved
0.6265 Remote Similarity NPD8378 Approved
0.6264 Remote Similarity NPD7390 Discontinued
0.6262 Remote Similarity NPD8285 Discontinued
0.6258 Remote Similarity NPD5951 Approved
0.6242 Remote Similarity NPD7516 Approved
0.6236 Remote Similarity NPD5406 Approved
0.6236 Remote Similarity NPD5405 Approved
0.6236 Remote Similarity NPD5404 Approved
0.6236 Remote Similarity NPD5408 Approved
0.6231 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6222 Remote Similarity NPD6674 Discontinued
0.6209 Remote Similarity NPD7584 Approved
0.6205 Remote Similarity NPD8377 Approved
0.6205 Remote Similarity NPD8294 Approved
0.6193 Remote Similarity NPD230 Phase 1
0.6188 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6188 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6182 Remote Similarity NPD7327 Approved
0.6182 Remote Similarity NPD7328 Approved
0.618 Remote Similarity NPD2799 Discontinued
0.6167 Remote Similarity NPD1549 Phase 2
0.6154 Remote Similarity NPD7274 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data